Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 ...

DUBAI, 7th July, 2026 (WAM) -- Dubai Press Club has announced the launch of the third edition of the Arab Podcast Program, an initiative designed to advance the Arab podcasting industry by equipping ...

CEO Thomas Equels discusses recent clinical progress, upcoming milestones and the Company's commitment to advancing Ampligen® for patients with pancreatic cancer ...

Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial R ...

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

After losing civil service protections, some federal employees now in Schedule Policy/Career fear for their job security and ...

C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ...

This secular, queer friendly addiction recovery group presents July opportunities. A weekly support group meets every Monday ...

When workers at Irving Shipbuilding Inc. lowered a silver coin into the hull of Canada’s first River-class destroyer last ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an ...

Alpha Tau Medical (DRTS) pioneers alpha emitter-based targeted radiation therapy, aiming for highly localized tumor ...